72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension

INTRODUCTION: The long-term safety of dimethyl fumarate (DMF) in patients with relapsing-remitting multiple sclerosis (RRMS) has been studied in mainly Caucasian patients. The present interim analysis aimed to evaluate the 72-week safety of DMF in Japanese patients with RRMS. METHODS: Safety data of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochi, Hirofumi, Niino, Masaaki, Onizuka, Yasuhiro, Hiramatsu, Katsutoshi, Hase, Masakazu, Yun, Jang, Matta, André, Torii, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182629/
https://www.ncbi.nlm.nih.gov/pubmed/30206820
http://dx.doi.org/10.1007/s12325-018-0788-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182629/
https://www.ncbi.nlm.nih.gov/pubmed/30206820
http://dx.doi.org/10.1007/s12325-018-0788-8

Ejemplares similares